Oral Health Status and Factors Related to Oral Health in Patients with Schizophrenia: A Matched Case-Control Observational Study

被引:2
|
作者
Sherbaf, Reza Aghasizadeh [1 ]
Kaposvari, George Michael [1 ]
Nagy, Katalin [1 ]
Almos, Zoltan Peter [2 ]
Barath, Zoltan [3 ]
Matusovits, Danica [1 ]
机构
[1] Univ Szeged, Fac Dent, Dept Oral Surg, Tisza Laj Krt 64-66, H-6720 Szeged, Hungary
[2] Univ Szeged, Fac Med, Dept Psychiat, Koranyi Fasor 8-10, H-6720 Szeged, Hungary
[3] Univ Szeged, Fac Dent, Dept Prosthodont, Tisza Laj Krt 64-66, H-6720 Szeged, Hungary
关键词
schizophrenia; mental disorder; oral health; dental status; periodontal status; DMF-T; case-control study; DENTAL-HEALTH; PEOPLE; MEDICATIONS; PREVALENCE; CARE;
D O I
10.3390/jcm13061584
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Schizophrenia (SCZ) patients have disproportionately poor oral health outcomes owing to a multidimensional set of factors, such as pathophysiology of the disease, drug-related adverse effects and lower utilization rate of dental healthcare services. The aim of the present observational study was to compare the indicators of dental and periodontal health in patients with SCZ to those of nonaffected healthy controls; furthermore, the influence of various anamnestic factors and lifestyle habits on oral health status were also assessed. Methods: A total of 50 SCZ patients-in remission-receiving treatment at the Department of Psychiatry, University of Szeged, were compared with 50 age- and gender-matched healthy controls attending the Faculty of Dentistry, University of Szeged. Participants' dental (decayed, missing and filled surfaces [DMF-S] and decayed, missing and filled teeth [DMF-T]) and periodontal (plaque index [%], bleeding on probing [BOP%], pocket depth [PD] and attachment loss [AL]) status was measured according to the World Health Organization (WHO) criteria. Results: In total, 74.0%, 80.0% and 78.0% of SCZ patients received second-generation antipsychotics, benzodiazepines and mood stabilizers, respectively. Patients with SCZ had significantly higher DMFs (81.30 +/- 40.16 vs. 61.64 +/- 40.56; p = 0.010), D (8.18 +/- 7.73 vs. 4.18 +/- 4.22; p < 0.001) and DMF-T (18.20 +/- 8.36 vs. 14.42 +/- 8.21; p = 0.024) scores but significantly lower F (1.84 +/- 0.29 vs. 4.62 +/- 3.98; p < 0.001) scores compared to the controls; male subjects had significantly lower DMFs (74.52 +/- 39.72 vs. 90.67 +/- 39.1; p = 0.020) and DMF-T (16.52 +/- 8.12 vs. 20.52 +/- 8.32; p = 0.031) scores. Additionally, SCZ patients had significantly higher plaque indices (56.96 +/- 23.19 vs. 27.44 +/- 17.53; p < 0.001), BOP% (58.96 +/- 22.89 vs. 23.56 +/- 17.53; p < 0.001), PD (2.84 +/- 0.67 vs. 2.19 +/- 0.49; p = 0.024) and AL (3.39 +/- 1.72 vs. 2.49 +/- 0.76; p < 0.001) values compared to controls. Smoking > 10 cigarettes/day was associated with worse dental and periodontal indices, while consuming >= 4 units/week of alcohol was associated with worse periodontal indices, respectively (p < 0.05 in all cases). In contrast, coffee consumption rates and vitamin supplementation status had no significant effect on oral health status indicators. Conclusions: Our study highlights the overall poor oral health status of individuals affected by SCZ and the need for targeted preventive interventions.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] A case-control study on oral health-related quality of life in kidney disease patients undergoing haemodialysis
    Pakpour, Amir H.
    Kumar, Santhosh
    Fridlund, Bengt
    Zimmer, Stefan
    CLINICAL ORAL INVESTIGATIONS, 2015, 19 (06) : 1235 - 1243
  • [32] A case-control study on oral health-related quality of life in kidney disease patients undergoing haemodialysis
    Amir H. Pakpour
    Santhosh Kumar
    Bengt Fridlund
    Stefan Zimmer
    Clinical Oral Investigations, 2015, 19 : 1235 - 1243
  • [33] Oral health-related quality of life in Iranian patients with spinal cord injury: A case-control study
    Pakpour, Amir H.
    Kumar, Santhosh
    Scheerman, Janneke F. M.
    Lin, Chung-Ying
    Fridlund, Bengt
    Jansson, Henrik
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2016, 47 (06): : 1345 - 1352
  • [34] Oral function in amyotrophic lateral sclerosis patients: A matched case-control study
    Schimmel, Martin
    Leuchter, Igor
    Barras, Anne-Chantal Heritier
    Leles, Claudio R.
    Abou-Ayash, Samir
    Viatte, Valerie
    Esteve, Francoise
    Janssens, Jean-Paul
    Mueller, Frauke
    Genton, Laurence
    CLINICAL NUTRITION, 2021, 40 (08) : 4904 - 4911
  • [35] Chronic disease comorbidity in patients with oral leukoplakia: A matched case-control study
    Giudice, Lance W.
    Graff, Emrik A.
    Haripersad, Yasmita
    Frydrych, Agnieszka M.
    Parsons, Richard
    Kujan, Omar
    Farah, Camile S.
    ORAL DISEASES, 2020, 26 (05) : 894 - 902
  • [36] ORAL HEALTH AND FACTORS RELATED TO ORAL HEALTH IN POLISH SCHOOLCHILDREN
    WIERZBICKA, M
    CARLSSON, P
    STRUZYCKA, I
    IWANICKAFRANKOWSKA, E
    BRATTHALL, D
    COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 1987, 15 (04) : 216 - 217
  • [37] Poor Oral Health and Coronary Artery Disease: A Case-Control Study
    Ashraf, Javed
    Bokhari, Syed Akhtar Hussain
    Manzoor, Sobia
    Khan, Ayyaz Ali
    JOURNAL OF PERIODONTOLOGY, 2012, 83 (11) : 1382 - 1387
  • [38] Association of Adult Atopic Dermatitis with Impaired Oral Health and Oral Dysbiosis: A Case-Control Study
    Shahin, Aaya
    Leshem, Yael Anne
    Taieb, Yossi
    Baum, Sharon
    Barzilai, Aviv
    Jeddah, Danielle
    Sharon, Efrat
    Koren, Omry
    Tzach-Nahman, Rinat
    Coppenhagen-Glazer, Shunit
    Hazan, Ronen
    Houri-Haddad, Yael
    Greenberger, Shoshana
    INTERNATIONAL DENTAL JOURNAL, 2025, 75 (01) : 279 - 287
  • [39] Oral health in Alzheimer's disease: a multicenter case-control study
    Aragon, F.
    Zea-Sevilla, M. A.
    Montero, J.
    Sancho, P.
    Corral, R.
    Tejedor, C.
    Frades-Payo, B.
    Paredes-Gallardo, V.
    Albaladejo, A.
    CLINICAL ORAL INVESTIGATIONS, 2018, 22 (09) : 3061 - 3070
  • [40] Oral health in Alzheimer’s disease: a multicenter case-control study
    F. Aragón
    M. A. Zea-Sevilla
    J. Montero
    P. Sancho
    R. Corral
    C. Tejedor
    B. Frades-Payo
    V. Paredes-Gallardo
    A. Albaladejo
    Clinical Oral Investigations, 2018, 22 : 3061 - 3070